Application of CRISPR/Cas9 lentiviral vector in construction of rat hepatic stellate cells with COX-2 gene knockout

Min PENG; Ting CAO; Xuefeng YANG; Shijie YI; Nian FU; Kebing ZHOU; Jianwu LONG

doi:10.3969/j.issn.1001-5256.2021.02.018

Volume 37 Issue 2

Mar. 2021

Turn off MathJax

Article Contents

Article Navigation > Journal of Clinical Hepatology > 2021 > 37(2): 336-342

PDF( 6689 KB)

Application of CRISPR/Cas9 lentiviral vector in construction of rat hepatic stellate cells with COX-2 gene knockout

DOI: 10.3969/j.issn.1001-5256.2021.02.018

Department of Gastroenterology, Nanhua Hospital Affiliated to Nanhua University, Hengyang, Hunan 421002, China

Received Date: 2020-07-29
Accepted Date: 2020-10-12
Published Date: 2021-02-20

Abstract

Abstract

Objective To obtain HSC-T6 cells with stable expression of Cas9 protein and HSC-T6-COX-2^-/- cells with COX-2 gene defect by transfecting HSC-T6 cells with CRISPR/Cas9 lentiviral vector, and to provide a good method for further functional research and new strategies for the clinical treatment of liver fibrosis. Methods The COX-2 gene-specific sgRNAs (COX-2-sgRNA-1, COX-2-sgRNA-2, COX-2-sgRNA-3) were designed, synthesized, and connected to the GV371 vector, and the recombinant plasmid and the packaging plasmid were transfected into 293T cells to form lentivirus particles; the fluorescence method was used to measure virus titer. The most appropriate amount of the virus was calculated based on MOI. Lenti-Cas9-puro was transfected into HSC-T6 cells, and HSC-T6-Cas9 cells were screened out by puromycin; Lenti-COX-2-sgRNA-EGFP was transfected into HSC-T6-Cas9 cells to obtain HSC-T6-COX-2^-/- cells. Cruiser enzyme digestion and Western blot were used to verify gene knockout at the gene and protein levels. An analysis of variance was used for comparison of continuous data between multiple groups, and the least significant difference t-test was used for further comparison between two groups. Results Sequencing verified that the COX-2-sgRNA expression vector was constructed successfully. Recombinant expression plasmids and packaging plasmids were transfected into 293T cells to form lentivirus particles, and the fluorescence method showed a virus titer of > 1×10⁸. HSC-T6 cells with stable expression of Cas9 protein and HSC-T6-COX-2^-/- cells with COX-2 gene defect were successfully constructed. The HSC-T6-Cas9 group had significantly higher relative mRNA expression of LV-Cas9-Puro than the CON group (541.93±105.76 vs 1.00±0.02, t=12.995, P < 0.01). Cruiser enzyme digestion and Western blot showed that the CRISPR/Cas9 lentivirus expression vectors played a role in the target, among which COX-2-sgRNA-2 knockout had the most significant effect, and this group had a significant reduction in the protein expression level of COX-2 compared with the CON group and the NC group (both P < 0.05), suggesting that COX-2-sgRNA was active. Conclusion A CRISPR/Cas9 lentivirus vector is successfully constructed for COX-2 target gene, and HSC-T6-COX-2^-/- cells with stable COX-2 gene knockout are obtained.
- Liver Cirrhosis,
- Clustered Regularly Interspaced Short Palindromic Repeats,
- Lentivirus Infections,
- Gene Knockout Techniques

FullText(HTML)

References(18)

References

[1]	DUVAL F, MORENO-CUEVAS JE, GONZÁLEZ-GARZA MT, et al. Liver fibrosis and mechanisms of the protective action of medicinal plants targeting inflammation and the immune response[J]. Int J Inflam, 2015, 2015: 943497.
[2]	XIE AZ, LYU C, SHI QL, et al. Research progress on prevention and treatment of liver fibrosis by traditional Chinese medicine[J]. China Med Herald, 2020, 17(17): 34-37. (in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY202017009.htm 谢爱泽, 吕超, 石清兰, 等. 中医药防治肝纤维化机制的研究进展[J]. 中国医药导报, 2020, 17(17): 34-37. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY202017009.htm
[3]	YIN W, YANG XF. Effects of phospholipase C_γ and cyclooxygenase-2 on the proliferation of hepatic stellate cells[J]. Mod Med Health, 2014, 30(3): 389-391. (in Chinese) DOI: 10.3969/j.issn.1009-5519.2014.03.030 尹微, 阳学风. 磷脂酶C_γ和环氧合酶-2对肝星状细胞增殖的影响[J]. 现代医药卫生, 2014, 30(3): 389-391. DOI: 10.3969/j.issn.1009-5519.2014.03.030
[4]	XIA HS, CHEN SR, ZHONG YC, et al. Current status of pathogenesis and drug treatment of liver fibrosis[J]. China Med Herald, 2014, 11(18): 162-165, 168.(in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY201418051.htm 夏海珊, 陈少茹, 钟月春, 等. 肝纤维化的发病机制和药物治疗现况[J]. 中国医药导报, 2014, 11(18): 162-165, 168. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY201418051.htm
[5]	CHENG J, IMANISHI H, ⅡJIMA H, et al. Expression of cyclooxygenase 2 and cytosolic phospholipase A(2) in the liver tissue of patients with chronic hepatitis and liver cirrhosis[J]. Hepatol Res, 2002, 23(3): 185-195. DOI: 10.1016/S1386-6346(01)00177-2
[6]	TANG SH, GAO JH, WEN SL, et al. Expression of cyclooxygenase-2 is correlated with lncRNA-COX-2 in cirrhotic mice induced by carbon tetrachloride[J]. Mol Med Rep, 2017, 15(4): 1507-1512. DOI: 10.3892/mmr.2017.6161
[7]	WANG CJ.Effect of aspirin on proliferation and activation of cultured HSC-T6 cells and its molecular mechanism[D]. Changsha: Central South University, 2012. (in Chinese) 王春江. 阿司匹林对培养的HSC-T6细胞增殖与活化的影响及分子机制研究[D]. 长沙: 中南大学, 2012.
[8]	ZHANG S. COX-2 regulates the proliferation of HSC-T6 cells and the expression of ACSL family genes through AA[D]. Hengyang: The University of South China, 2014. (in Chinese) 章烁. COX-2通过AA对HSC-T6细胞增殖及Acsl家族基因表达的调控[D]. 衡阳: 南华大学, 2014.
[9]	BITENCOURT S, de MESQUITA FC, CABERLON E, et al. Capsaicin induces de-differentiation of activated hepatic stellate cell[J]. Biochem Cell Biol, 2012, 90(6): 683-690. DOI: 10.1139/o2012-026
[10]	MOU H, SMITH JL, PENG L, et al. CRISPR/Cas9-mediated genome editing induces exon skipping by alternative splicing or exon deletion[J]. Genome Biol, 2017, 18(1): 108. DOI: 10.1186/s13059-017-1237-8
[11]	HUANG XL, LIU YY, CONG M. Research advances in drug carrier systems targeting hepatic stellate cells[J]. J Clin Hepatol, 2020, 36(1): 208-212. (in Chinese) DOI: 10.3969/j.issn.1001-5256.2020.01.050 黄小莉, 刘莹莹, 丛敏. 以肝星状细胞为靶向的药物载体系统[J]. 临床肝胆病杂志, 2020, 36(1): 208-212. DOI: 10.3969/j.issn.1001-5256.2020.01.050
[12]	CHEN Y, WANG Y, YANG Y, et al. A molecular-logic gate for COX-2 and NAT based on conformational and structural changes: Visualizing the progression of liver disease[J]. Chem Sci, 2020, 11(24): 6209-6216. DOI: 10.1039/D0SC00574F
[13]	HE J, LIAO HW, YANG XF. Construction of PSCSI-GFP lentiviral for the endothelin-converting enzyme-like 1 gene[J]. J Clin Hepatol, 2019, 35(6): 1286-1292. (in Chinese) DOI: 10.3969/j.issn.1001-5256.2019.06.021 何剑, 廖红伍, 阳学风. ECEL1基因PSCSI-GFP慢病毒载体的构建[J]. 临床肝胆病杂志, 2019, 35(6): 1286-1292. DOI: 10.3969/j.issn.1001-5256.2019.06.021
[14]	LE C, RAN FA, COX D, et al. Multiplex genome engineering using CRISPR/Cas systems[J]. Trends in Genetics Tig, 2013, 32(12): 815.
[15]	RAN FA, HSU PD, WRIGHT J, et al. Genome engineering using the CRISPR-Cas9 system[J]. Nat Protoc, 2013, 8(11): 2281-2308. DOI: 10.1038/nprot.2013.143
[16]	KONERMANN S, BRIGHAM MD, TREVINO AE, et al. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex[J]. Nature, 2015, 517(7536): 583-588. DOI: 10.1038/nature14136
[17]	LI SN, WANG MX, HU WD, et al. Construction and identification of miR-186 over expression lentiviral vector[J]. J Jilin Univ(Med Edit), 2019, 45(5):997-1002, 1193. (in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-BQEB201905004.htm 李胜男, 王梦旭, 胡伟东, 等. miR-186过表达慢病毒载体的构建及鉴定[J]. 吉林大学学报(医学版), 2019, 45(5): 997-1002, 1193. https://www.cnki.com.cn/Article/CJFDTOTAL-BQEB201905004.htm
[18]	VOIT RA, McMAHON MA, SAWYER SL, et al. Generation of an HIV resistant T-cell line by targeted "stacking" of restriction factors[J]. Mol Ther, 2013, 21(4): 786-795. DOI: 10.1038/mt.2012.284

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(10) / Tables(3)

Get Citation

PDF

XML

Article Metrics

Article views (1145) PDF downloads(68)

Application of CRISPR/Cas9 lentiviral vector in construction of rat hepatic stellate cells with COX-2 gene knockout

DOI: 10.3969/j.issn.1001-5256.2021.02.018

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Application of CRISPR/Cas9 lentiviral vector in construction of rat hepatic stellate cells with COX-2 gene knockout

DOI: 10.3969/j.issn.1001-5256.2021.02.018

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content